Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals of either sex above 18 2. People who have been tested positive to be infected with SARS-CoV2 virus and presenting with no symptoms or mild to moderate symptoms. 3. Subject who agrees for giving informed consent and provide signed and dated written IEC approved Informed Consent Form (ICF) prior to initiation of any study procedures
Exclusion criteria
Exclusion criteria: 1. Subjects who are not able to or not willing to sign an IRB/IEC approved consent form. 2. COVID patients with symptoms classified as severe or critical. 3. Persons with severe primary respiratory disease or other pneumonia 4. Pregnant women 5. Persons with serious complications of diseases such as cancer, heart disease, stroke, disabilities, mental illnesses, etc., and who are considered to be excluded from the study as evaluated by the investigators 6. COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in result of RT-PCR test for SARS-CoV2Timepoint: Day 1 and 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Length of time to clinical improvement 2. Percent mortality 3. Change in IgG and IgM levels in serum (Day 1 & Day 8) 4. Change in O2 Saturation 5. Defervescence of feverTimepoint: Day 1 and 8 | — |
Countries
India
Contacts
Shri Sant Dnyaneshwar Mauli Ayurved Pratishthan, Beed